| scholarly article | Q13442814 |
| P50 | author | Brenda Penninx | Q21255846 |
| Luigi Ferrucci | Q28050062 | ||
| Stefania Bandinelli | Q28050064 | ||
| Jack Guralnik | Q88679387 | ||
| Yuri Milaneschi | Q92828534 | ||
| Anna Maria Corsi | Q114408181 | ||
| P2860 | cites work | Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein | Q24310224 |
| A modified poisson regression approach to prospective studies with binary data | Q29615575 | ||
| Major depression and activation of the inflammatory response system | Q33708105 | ||
| Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. | Q33939777 | ||
| The immune system, depression and the action of antidepressants | Q34268481 | ||
| Depression in the elderly | Q34423873 | ||
| Stress, depression and the activation of the immune system | Q35073847 | ||
| Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes | Q35195619 | ||
| Cytokines and major depression | Q36031971 | ||
| IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress | Q36393030 | ||
| Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression | Q36637116 | ||
| Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study | Q37408150 | ||
| Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. | Q39555048 | ||
| A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission | Q39605905 | ||
| Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response | Q40531797 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. | Q43942974 | ||
| Depressive symptoms and physical decline in community-dwelling older persons | Q45117826 | ||
| Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus | Q45730010 | ||
| The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation | Q46862597 | ||
| Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women | Q47344631 | ||
| Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale | Q47578666 | ||
| Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study | Q47657388 | ||
| Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes | Q47914147 | ||
| The role of the vagus nerve in cytokine-to-brain communication | Q47966675 | ||
| Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease | Q48738007 | ||
| Increased serum interleukin-1-receptor-antagonist concentrations in major depression. | Q50981655 | ||
| Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. | Q51107702 | ||
| Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. | Q51906048 | ||
| Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. | Q51996803 | ||
| Production of interleukin-1-receptor antagonist during experimental endotoxaemia | Q54687598 | ||
| Immunological differences between patients with major depression and somatization syndrome | Q56767249 | ||
| Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion | Q56767354 | ||
| Indicators of immune activation in major depression | Q56767446 | ||
| Increase in Interleukin-1β in Late-Life Depression | Q57813826 | ||
| Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events | Q58230314 | ||
| Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials | Q59192158 | ||
| Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier | Q72429000 | ||
| Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression | Q72674139 | ||
| Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? | Q72824707 | ||
| The natural history of late-life depression: a 6-year prospective study in the community | Q74387009 | ||
| Inflammatory markers in late-life depression: results from a population-based study | Q80837482 | ||
| The origins of age-related proinflammatory state | Q81079607 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 973-978 | |
| P577 | publication date | 2008-12-25 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study | |
| P478 | volume | 65 |
| Q59355038 | A Longitudinal Study of the Association Between Persistent Pathogens and Incident Depression Among Older US Latinos |
| Q50130902 | Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder |
| Q54224164 | Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores. |
| Q48191933 | Associations of cytokine genes with Alzheimer's disease and depression in an elderly Korean population |
| Q36780771 | Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease |
| Q33646020 | C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression |
| Q35531978 | Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial |
| Q36061675 | Current understanding of the bi-directional relationship of major depression with inflammation |
| Q38229434 | Current understanding of the neurobiology and longitudinal course of geriatric depression |
| Q37884614 | Cytokines and depression: findings, issues, and treatment implications |
| Q37193811 | Depressive symptoms are associated with reduced neutrophil function in hip fracture patients |
| Q34569113 | Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q28571669 | Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells |
| Q44111293 | Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations. |
| Q94599540 | Genetic susceptibility, inflammation and specific types of depressive symptoms: evidence from the English Longitudinal Study of Ageing |
| Q35012816 | Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents |
| Q58786722 | IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis |
| Q34997238 | Immunity, aging, and geriatric depression |
| Q28394768 | Increased risk of nonalcoholic fatty liver disease with occupational stress in Chinese policemen: A 4-year cohort study |
| Q34147377 | Inflammation-associated depression: from serotonin to kynurenine |
| Q47770362 | Inflammatory dietary patterns and depressive symptoms in Italian older adults |
| Q98305996 | Investigating data-driven biological subtypes of sychiatric disorders using specification-curve analysis |
| Q49010960 | Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression? |
| Q35620597 | Is the Relationship between Common Mental Disorder and Adiposity Bidirectional? Prospective Analyses of a UK General Population-Based Study |
| Q47719124 | Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia |
| Q33648256 | Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms |
| Q92431520 | Mechanisms and treatment of late-life depression |
| Q47751467 | Multi-Domains Lifestyle Interventions Reduces Depressive Symptoms among Frail and Pre-Frail Older Persons: Randomized Controlled Trial |
| Q36896665 | Neuro-oncology family caregivers are at risk for systemic inflammation |
| Q26775794 | Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology |
| Q38287778 | Obesity and symptoms of depression among adults in selected countries of the Middle East: a systematic review and meta-analysis. |
| Q38230661 | Perfusion deficits, inflammation and aging precipitate depressive behaviour |
| Q28079484 | Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review |
| Q39356952 | Physical frailty: vulnerability of patients suffering from late-life depression |
| Q37769293 | Preventing late-life depression: a clinical update |
| Q40708687 | Relationship Between Physical Frailty and Low-Grade Inflammation in Late-Life Depression |
| Q91014092 | Repeat length variations in polyglutamine disease-associated genes affect body mass index |
| Q57134994 | Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis |
| Q47767853 | Serum interleukin-6 is related to lower cognitive functioning in elderly patients with major depression |
| Q37347574 | Serum proteomic profiling of major depressive disorder |
| Q37432371 | Sleep loss and its effects on health of family caregivers of individuals with primary malignant brain tumors |
| Q38038284 | Targeting IL-1 in depression |
| Q56767037 | The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder |
| Q34429441 | The association between leptin and depressive symptoms is modulated by abdominal adiposity |
| Q35177870 | The inflammation hypothesis in geriatric depression |
| Q98513654 | The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression |
| Q38151954 | The neuro-immune axis: prospect for novel treatments for mental disorders |
| Q47118363 | The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus |
| Q38260605 | The relationship between depression and frailty syndrome: a systematic review. |
| Q33578766 | The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder |
| Q35990267 | The relationship between plasma carotenoids and depressive symptoms in older persons |
| Q51082275 | The role of interleukin genes in the course of depression. |
| Q58782352 | Understanding depression in type 2 diabetes: a biological approach in observational studies |
Search more.